[1] Kujawa KA, Lisowska KM. Ovarian cancer——from biology to clinic[J].Postepy Hig Med Dosw(Online), 2015, 69:1275-1290. [2] Dong X, Men X, Zhang W, et al. Advances in tumor markers of ovarian cancer for early diagnosis[J]. Indian J Cancer, 2014, 51(3):72-76. [3] De Felice F, Marchetti C, Di Mino A, et al. Recurrent Ovarian Cancer:The Role of Radiation Therapy[J]. Int J Gynecol Cancer, 2017, 27(4):690-695. [4] Liao Q, Zhang HM, Li HH,et al. A preliminary study on the radiation-resistance mechanism in ovarian cancer[J]. J Cancer Res Ther,2013,9(1):22-24. [5] Reddy KB. MicroRNA (miRNA) in cancer[J]. Cancer Cell Int, 2015,15:38. [6] 霍红日,杨智勇,朱玲莉. miRNA-193a在肺腺癌患者体内的表达水平及意义[J]. 国际检验医学杂志,2017, 38(13):1773-1775. [7] Wu Q, Yang Z, Shi Y, et al. MiRNAs in human cancers:the diagnostic and therapeutic implications[J]. Curr Pharm Des, 2014, 20(33):5336-5347. [8] Li Y, Fang Y, Liu Y, et al. MicroRNAs in ovarian function and disorders[J].J Ovarian Res, 2015,8:51. [9] Zhang S, Lu Z, Unruh AK, et al. Clinically relevant microRNAs in ovarian cancer[J].Mol Cancer Res, 2015,13(3):393-401. [10] Liu M, Zhang X, Hu CF, et al. MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells[J]. Chin J Cancer, 2014, 33(6):285-294. [11] Su Z, Yang Z, Xu Y, et al. MicroRNAs in apoptosis, autophagy and necroptosis[J]. Oncotarget, 2015, 6(11):8474-8490. [12] Wang ZH, Xu CJ. Research Progress of MicroRNA in Early Detection of Ovarian Cancer[J]. Chin Med J (Engl), 2015, 128(24):3363-3370. [13] Gao YC, Wu J.MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer[J]. Tumour Biol,2015,36(6):4843-4850. [14] Shapira I, Oswald M, Lovecchio J, et al. Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes[J]. Br J Cancer, 2014, 110(4):976-983. [15] Mahdian-Shakib A, Dorostkar R, Tat M, et al. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer[J]. Biomed Pharmacother, 2016, 84:592-600. [16] Pal MK, Jaiswar SP, Dwivedi VN, et al. MicroRNA:a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer[J]. Cancer Biol Med, 2015, 12(4):328-341. [17] Liu D, Xia H, Wang F, et al. MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer[J]. Onco Targets Ther, 2016, 9:5245-5255. [18] Li L, Huang K, You Y,et al. Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis[J]. Int J Oncol, 2014, 44(6):2111-2120. [19] 张萍,王敏,接智慧,等. miR-210在化疗耐药与化疗敏感卵巢浆液性癌组织中的检测及意义[J]. 中国医科大学学报, 2014, 43(6):487-492. [20] Rai B, Bansal A, Patel FD, et al. Radiotherapy for ovarian cancers-redefining the role[J]. Asian Pac J Cancer Prev, 2014, 15(12):4759-4763. [21] 刘书中,李子全,李政垚,等.外周血miR-21检测在胰腺癌中的意义研究进展[J].中国实验诊断学,2016,20(6):1038-1042. [22] 付霞霏,何援利,王雪峰,等.化疗性卵巢功能早衰动物模型及患者血清miR-21水平的变化[J].解放军医学杂志,2016,41(11):915-918. |